PABCX
Price
$19.69
Change
+$0.10 (+0.51%)
Updated
Nov 26 closing price
Net Assets
1.06B
RLBFX
Price
$39.88
Change
+$0.25 (+0.63%)
Updated
Nov 26 closing price
Net Assets
269.83B
Interact to see
Advertisement

PABCX vs RLBFX

Header iconPABCX vs RLBFX Comparison
Open Charts PABCX vs RLBFXBanner chart's image
PGIM Balanced C
Price$19.69
Change+$0.10 (+0.51%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R5
Price$39.88
Change+$0.25 (+0.63%)
VolumeN/A
Net Assets269.83B
PABCX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
PABCX vs. RLBFX commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABCX is a StrongBuy and RLBFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 270B vs. PABCX (1.06B). RLBFX pays higher dividends than PABCX: RLBFX (1.97) vs PABCX (1.20). PABCX was incepted earlier than RLBFX: PABCX (29 years) vs RLBFX (24 years). PABCX (1.87) is less costly to investors than RLBFX (0.29). PABCX is a more actively managed with annual turnover of: 107.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than PABCX: RLBFX (250) vs PABCX (1000). RLBFX annual gain was more profitable for investors over the last year : 10.52 vs. PABCX (5.99). RLBFX return over 5 years is better than : 42.08 vs. PABCX (21.05).
PABCXRLBFXPABCX / RLBFX
Total Expense Ratio1.810.29624%
Annual Report Gross Expense Ratio1.870.29645%
Fund Existence29 years24 years-
Gain YTD13.70817.24280%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B270B0%
Annual Yield % from dividends1.201.9761%
Returns for 1 year5.9910.5257%
Returns for 3 years36.4043.7783%
Returns for 5 years21.0542.0850%
Returns for 10 years37.1778.6147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNTI2.110.03
+1.44%
Senti Biosciences Inc.
BRRWU10.50N/A
N/A
Columbus Circle Capital Corp I
HALO72.66-0.16
-0.22%
Halozyme Therapeutics
QURE27.63-0.33
-1.18%
uniQure NV
AUTL1.37-0.02
-1.44%
Autolus Therapeutics plc